With reference to the earlier letter dated May 13, 2022 intimating about the meeting of the Board of Directors of the Company scheduled to be held on May 20, 2022.<BR><BR>Zydus Lifesciences Ltd has now informed BSE that the Board of Directors of the Company, at its aforesaid meeting, will also consider a proposal for buyback of fully paid-up equity shares of the Company and the matters necessary and incidental thereto, in accordance with the applicable provisions under the Companies Act, 2013 (including the rules and regulations framed thereunder), the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended, and other applicable laws.
|